Impact of romosozumab on bone mineral density in postmenopausal osteoporosis

被引：0
|
作者：
Azharuddin, Md [1 ]
Sharma, Manju [1 ]
机构：
[1] Jamia Hamdard, Sch Pharmaceut Educ & Res, New Delhi, India
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2022年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
720
引用
收藏
页码：330 / 330
页数：1
相关论文
共 50 条
  • [21] Romosozumab Treatment in Postmenopausal Osteoporosis
    Banhidy, Norbert F.
    MacKinnon, Thomas S.
    Banhidy, Francis P.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (04): : 395 - 395
  • [22] Effect of alendronate on bone mineral density and bone turnover in Thai postmenopausal osteoporosis
    La-or Chailurkit
    Wallaya Jongjaroenprasert
    Sasithorn Rungbunnapun
    Boonsong Ongphiphadhanakul
    Sunee Sae-tung
    Rajata Rajatanavin
    [J]. Journal of Bone and Mineral Metabolism, 2003, 21 : 421 - 427
  • [23] CORRELATIONS BETWEEN THE MARKERS OF BONE REMODELING AND BONE MINERAL DENSITY IN POSTMENOPAUSAL OSTEOPOROSIS
    Gurban, C.
    Zosin, I.
    Gotia, S.
    Sfrijan, F.
    Gotia, L.
    Radulov, I.
    Savescu, I.
    Drugarin, D.
    [J]. ACTA ENDOCRINOLOGICA-BUCHAREST, 2010, 6 (01) : 27 - 34
  • [24] Effect of alendronate on bone mineral density and bone turnover in Thai postmenopausal osteoporosis
    Chailurkit, LO
    Jongjaroenprasert, W
    Rungbunnapun, S
    Ongphiphadhanakul, B
    Sae-Tung, S
    Rajatanavin, R
    [J]. JOURNAL OF BONE AND MINERAL METABOLISM, 2003, 21 (06) : 421 - 427
  • [25] Correlations between the bone matrix markers and bone mineral density in postmenopausal osteoporosis
    Gurban, C. V.
    Vlad, D. C.
    Zosin, I.
    Gotia, S. R.
    Balas, M.
    Gotia, L.
    Savescu, I. C.
    Radulov, I.
    [J]. CLINICAL BIOCHEMISTRY, 2011, 44 (13) : 1184 - 1185
  • [26] Impact of the duration of previous osteoporosis treatment on the effect of romosozumab in patients with postmenopausal osteoporosis
    Ebina, Kosuke
    Etani, Yuki
    Tsuboi, Hideki
    Nagayama, Yoshio
    Kashii, Masafumi
    Miyama, Akira
    Kunugiza, Yasuo
    Hirao, Makoto
    Okamura, Gensuke
    Noguchi, Takaaki
    Takami, Kenji
    Goshima, Atsushi
    Miura, Taihei
    Fukuda, Yuji
    Kurihara, Takuya
    Okada, Seiji
    Nakata, Ken
    [J]. OSTEOPOROSIS INTERNATIONAL, 2022, 33 (11) : 2441 - 2443
  • [27] BONE MINERAL DENSITY IN PATIENTS WITH AROMATASE INHIBITORS COMPARED TO POSTMENOPAUSAL OSTEOPOROSIS
    Oncu, J.
    Kuran, B.
    Sen, N.
    Yilmaz, F.
    Ercalik, C.
    Dogu, B.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2016, 27 : S476 - S477
  • [28] Serum osteoprotegerin and bone mineral density in postmenopausal women with or without osteoporosis
    不详
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2006, 78 : S99 - S99
  • [29] Is leptin a determinant of bone mineral density in Turkish postmenopausal women with osteoporosis
    Sahin, G
    Polat, G
    Çimen, ÖB
    Bycer, A
    Incel, NA
    Bagis, S
    Guler, H
    Erdogan, C
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 445 - 446
  • [30] Impact of the duration of previous osteoporosis treatment on the effect of romosozumab in patients with postmenopausal osteoporosis
    Kosuke Ebina
    Yuki Etani
    Hideki Tsuboi
    Yoshio Nagayama
    Masafumi Kashii
    Akira Miyama
    Yasuo Kunugiza
    Makoto Hirao
    Gensuke Okamura
    Takaaki Noguchi
    Kenji Takami
    Atsushi Goshima
    Taihei Miura
    Yuji Fukuda
    Takuya Kurihara
    Seiji Okada
    Ken Nakata
    [J]. Osteoporosis International, 2022, 33 : 2441 - 2443
12345